Studies show that single-molecule dual GIPR/GLP-1R agonists have better insulinotropic and antihyperglycemic effects than GLP-1 agonists in rodents, primates, and humans, without causing gastrointestinal disturbances [58]
If you have any medical concerns or need urgent help, contact a healthcare professional or emergency services immediately
If it persists or progresses, dose reduction or switching to a more selective anti-androgen (e.g., bicalutamide) is the next step
Inflammation reduction Many report improvements in autoimmune conditions, joint pain, and skin health
Tirzepatide users had approximately half the cataract risk compared to some traditional medications
Microdosing GLP-1s is hardly a one-size fits all process, and its important to use a telehealth platform that offers a truly personalized plan